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Transcriptional profiling of liver in
riboflavin-deficient chicken embryos
explains impaired lipid utilization, energy
depletion, massive hemorrhaging, and
delayed feathering
Larry A. Cogburn1*, Danielle N. Smarsh1,3, Xiaofei Wang1,4, Nares Trakooljul1,5, Wilfrid Carré1,6
and Harold B. White III2

Abstract
Background: A strain of Leghorn chickens (rd/rd), unable to produce a functional riboflavin-binding protein, lays
riboflavin-deficient eggs, in which all embryos suddenly die at mid-incubation (days 13-15). This malady,
caused by riboflavin deficiency, leads to excessive lipid accumulation in liver, impaired β-oxidation of lipid,
and severe hypoglycemia prior to death. We have used high-density chicken microarrays for time-course
transcriptional scans of liver in chicken embryos between days 9-15 during this riboflavin-deficiency-induced
metabolic catastrophe. For comparison, half of rd/rd embryos (n = 16) were rescued from this calamity by
injection of riboflavin just prior to incubation of fertile eggs from rd/rd hens.
Results: No significant differences were found between hepatic transcriptomes of riboflavin-deficient and
riboflavin-rescued embryos at the first two ages (days 9 and 11). Overall, we found a 3.2-fold increase in the
number of differentially expressed hepatic genes between day 13 (231 genes) and day 15 (734 genes). Higher
expression of genes encoding the chicken flavoproteome was more evident in rescued- (15 genes) than in deficientembryos (4 genes) at day 15. Diminished activity of flavin-dependent enzymes in riboflavin-deficient embryos blocks
catabolism of yolk lipids, which normally serves as the predominant source of energy required for embryonic development.
Conclusions: Riboflavin deficiency in mid-stage embryos leads to reduced expression of numerous genes controlling
critical functions, including β-oxidation of lipids, blood coagulation and feathering. Surprisingly, reduced expression of
feather keratin 1 was found in liver of riboflavin-deficient embryos at e15, which could be related to their delayed
feathering and sparse clubbed down. A large number of genes are expressed at higher levels in liver of riboflavindeficient embryos; these up-regulated genes control lipid storage/transport, gluconeogenesis, ketogenesis, protein
catabolism/ubiquitination and cell death.
Keywords: Microarray analysis, Riboflavin deficiency, Expression profiling, Impaired lipid metabolism, β-oxidation,
Protein catabolism, Protease inhibitors, Coagulation factors, Acetyl CoA deficiency, Sudden embryonic death, Chicken
flavoproteome, Feather keratin
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Background
The 21-day development of a chicken embryo represents
the genetically and molecularly choreographed transformation of a fertilized egg into a complex living organism [1]. The cleidoic egg of birds is a self-contained, lifesupport system packaged by the hen that requires only
external heat and oxygen for development of the embryo
that hatches into a fully-functional, free-living, hatchling.
Within the protective shell and surrounding the yolk,
the egg white (albumen) provides a protein-rich antimicrobial barrier [2]. From our global transcriptional
analysis of the hen’s oviduct during formation of the egg,
we have described the orchestration of gene expression
during fabrication of the eggshell membranes and calcification of the egg shell during the egg’s transit through
each segment of the hen’s oviduct [3, 4]. Upon incubation, the fertilized ovum develops into an embryo at the
surface of the nutrient-rich yolk from which it derives
energy almost exclusively from the oxidation of lipids [5,
6]. The deficiency of a single trace nutrient, such as
riboflavin, creates a catastrophic metabolic crisis that
abruptly aborts the embryo’s developmental process.
Hens from a strain of White Leghorn chickens are unable to deposit riboflavin in their eggs due to a recessive
mutation (rd) [7, 8]. A single base substitution in the
donor splice site of intron 3 of the gene encoding the
riboflavin-binding protein (RBP) [9] causes skipping of
exon 3 [10], which subsequently prevents synthesis of a
functional RBP in the hen’s liver and oviduct for deposition of riboflavin into the yolk and albumen layers [11].
Small amounts of riboflavin, in its flavin-adenine dinucleotide (FAD) coenzyme form and associated with
the enzyme quiescin sulfhydryl oxidase (QSOX) [12], are
present in these eggs [13], this sustains riboflavindeficient embryos until death on day 13-15 of embryonation (e13-e15). Affected embryos have delayed and aberrant feather development (clubbed down), fatty livers
and extensive cutaneous hemorrhaging (Fig. 1a).
Riboflavin-deficient (Rf-) fertilized eggs are rescued by
injecting a small amount of more-soluble flavin coenzyme, riboflavin-5′-phosphate (FMN), into the albumen
prior to onset of incubation [7]. After hatching, the
riboflavin-rescued (Rf+) chicks absorb adequate amounts
of riboflavin from their diets and develop normally to
maturity. We found higher (normal) expression of numerous flavin-dependent genes in liver of Rf + embryos
at e15. Thus, this lethal mutation prevents riboflavin
transport from liver to the oviduct for delivery into the
egg. However, a single injection of FMN into the fertilized egg from rd/rd hens prior to onset of incubation
(e0) ameliorates this metabolic crisis. Redox coenzymes
derived from riboflavin (FMN and FAD) are essential
components of numerous flavoprotein enzymes that reduce molecular oxygen directly, as with QSOX, or
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Fig. 1 A Gross anatomy of riboflavin-deficient (A) and riboflavin-rescued
(B) chick embryos on embryonic day 15 (e15). The riboflavin-deficient
(Rf-) embryos present with extensive hemorrhage of skin, liver and heart,
retarded development of the eye, feathers, beak and cranium, and
excessive lipid deposition in the liver. On the other hand, the riboflavinrescued (Rf+) embryos show normal development of the head, feathers
and liver, which typically shows yellowing due to storage and utilization
of yolk lipids. Gross anatomy of Rf + and Rf- embryos at e15 was
documented using a Leica M420 macroscope (Buffalo Grove, IL) fitted
with a cold light source and the Spot Insight 4 imaging system. The
photomicrographs were taken at a magnification of 10X. B Venn
diagram of differentially-expressed (DE) and “Analysis Ready” (AR) genes
mapped to the Ingenuity Knowledge Base using Ingenuity® Pathway
Analysis (IPA) software. Statistical analysis showed no DE (FDR ≤ 0.05)
genes between the Rf + and Rf- embryos on e9 and e11. Of the 395 DE
genes identified in the liver at e13, only 221 DE genes (or 56%) were
considered by IPA as “Analysis Ready” (AR), which reflects incomplete
annotation of the Roslin chicken oligo printed on this array. Likewise,
1467 DE genes were identified from statistical analysis on e15; and of
these genes, only 929 (or 63%) were mapped to the Ingenuity®
Knowledge Base (i.e., AR-DE genes). While only 162 AR-DE genes were
commonly shared between riboflavin treatment groups across e13
and e15

indirectly via the mitochondrial electron transport system that generates ATP. Riboflavin-deficient embryos
experience a metabolic crisis when trace amounts of
riboflavin become depleted and are insufficient to meet
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the metabolic demands on these enzymes [14]. Although
Rf- embryos seem to grow normally with only a slight
reduction in body weight on the day before death, signs
of metabolic disruption appear around e10 when normal
chick embryos become almost totally dependent on catabolism of triglycerides stored in the yolk for metabolic
energy [15]. The five-fold increase in the activity of an
essential flavin-dependent enzyme in the beta oxidation
of fatty acids, medium-chain acyl-Coenzyme A dehydrogenase (MCAD), in liver and heart of normal embryos
reflects this major metabolic switch [16]. However, with
the limited riboflavin stores depleted, MCAD activity remains unchanged between day 10 and 14 of incubation
in riboflavin-deficient embryos. This impairment of
MCAD and other flavin-dependent enzymes leads to a
metabolic block that results in the observed accumulation of lipid in the embryonic liver, a dramatic 30-fold
increase in 10, 12, and 14-carbon intermediates of fatty
acid oxidation in liver, and the inability to synthesize
polyunsaturated fatty acids [16].
With fatty acid oxidation severely inhibited, it appears
that riboflavin-deficient embryos depend heavily on glycolysis for ATP production. Plasma glucose concentrations that remain relatively unchanged or even rise
slightly in normal embryos between day 10 and 14 of incubation, rapidly drop to near zero at the time of death
in Rf- embryos [16]. At the same time, lactate concentrations in allantoic fluid, an indicator of carbohydrate catabolism, remain higher than 2-hydroxybutyrate, a
ketone body produced during lipid catabolism. In normal embryos and riboflavin-deficient embryos supplemented with riboflavin, the concentration of 2-hydroxybutyrate is always higher than lactate in allantoic fluid. A
progressive decrease in heart rate in riboflavin-deficient
embryos [in a tissue with increasing demand for fatty
acid oxidation] [17] begins about 1 hour before death
suggesting that the rate of ATP production from lipid
and carbohydrate sources is insufficient to sustain cardiac muscle contraction and leads to death [16]. Thus,
the sudden death of all riboflavin-deficient chicken embryos results from a cascade of catastrophic events precipitated by depletion of trace amounts of riboflavin that
sustain the minimal demands of early embryo growth,
but become limiting after embryonic day 11 (e11) of the
21-day incubation period. Initially, riboflavin deficiency
inhibits fatty acid oxidation, the major energy source for
avian embryos, and causes excessive accumulation of
metabolic intermediates that sequester Coenzyme A
(CoA), which in turn has further inhibitory effects on
pathways generating ATP. The increased dependence on
glycolysis soon depletes the rd/rd embryo’s limited reserves of glucose, and then death soon ensues. In
humans, hereditary medium-chain acyl-coenzyme A dehydrogenase disorder (MCADD) can lead to sudden
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infant death due to the decreased ability to metabolize
lipids during an overnight fast [18]. The crisis in lipid
oxidation induced by acute riboflavin deficiency in
chicken embryos metabolically mimics the sudden infant
death syndrome due to MCADD. Several distinct tissues
express three major transporters for riboflavin in mammals: the placenta, intestine and kidney (RFVT1), the
brain (RFVT2), and visceral glands/organs (RFVT3)
[19]. In contrast, birds are oviparous animals, which require the dam to have a specialized system, the riboflavin binding protein (RBP), to transport riboflavin (Rf )
from the post-prandial liver to the oviduct for deposition
of essential riboflavin into the egg prior to oviposition,
incubation and embryonation. Consequently, RBP is the
highest expressed gene found in liver of the laying hen,
being 67-fold greater than in liver of non-laying chickens, using the same 20.7 K chicken oligo microarrays
used in the present study [20].
Here, we describe transcriptional changes in liver of
riboflavin-deficient chicken embryos, with or without
riboflavin supplementation, between embryonic day e9
and e15. Our goal was to identify riboflavin-specific responses by comparing riboflavin -rescued (Rf+) verses
riboflavin-deficient (Rf-) embryos during this abrupt
metabolic collapse. Our unique single-nutrient (Rf )
model allowed the identification of riboflavin-dependent
hepatic genes and their functional networks involved in
the switch to alternative energy sources and global adaptation to acute riboflavin deficiency, which leads to sudden embryo death just before or on e15. Our study
provides an excellent model of the maternal effect,
where the mother’s genotype (rd/rd) determines the survival of embryos, whereas the embryo’s genotype (rd/rd)
has little effect.

Methods
Experimental birds and riboflavin treatment

Single-Comb White Leghorn (SCWL) chickens, homozygous recessive for the riboflavin binding-protein
deficient-allele (rd/rd) were maintained at the University
of Delaware. The chickens were raised and cared for
under protocols approved by the Institutional Animal
Care and Use Committee (ICUC), University of Delaware. Fertile eggs, derived from riboflavin binding protein deficient (rd/rd) hens, were injected with riboflavin5′-phosphate (FMN) [riboflavin-rescued (Rf+)] or sterile
saline [riboflavin-deficient (Rf-)] at the onset of incubation (e0). A total of 150 fertile eggs were collected from
rd/rd hens and one-third of the eggs were each injected
with 100 μL of FMN (540 μg) just before onset of incubation (e0) and assigned to the riboflavin-rescued (Rf+)
treatment. The FMN (540 mg) was dissolved in 100 mL
of sterile normal (0.85 M) saline, the solution was then
filter sterilized and stored in darkness at 4 °C until
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usage. The remaining two-thirds of the eggs were
injected with 100 μL of sterile saline; these eggs were
assigned to the riboflavin-deficient (Rf-) treatment. The
eggs were then incubated in an automated Jamesway
Egg Incubator (Cambridge, ON, CDN) maintained at
39 °C and 95% relative humidity (RH). A larger number
of fertile riboflavin-deficient eggs were incubated to
compensate for very high mortality found in Rf- embryos at e13 and e15, since riboflavin deficiency was
100% lethal after e15 [21].
Liver sampling and RNA extraction

Eight viable embryos from each riboflavin treatment
group were killed for liver samples at two embryonic
ages (e9 and e11), while four individual liver samples
were collected from each group at e13, and e15 (Table 1).
Due to the very small size of liver in embryos at e9 and
e11, two livers from each riboflavin treatment group (Rf
+ and Rf-) were randomly selected and pooled in pairs
to represent each of the four biological replicates/riboflavin treatment used for RNA extraction at e9 and e11.
Liver samples were immediately placed in 2 ml Corning®
cryogenic vials, snap frozen in liquid nitrogen and stored
frozen at − 80 °C until processing for RNA. Thus, a total
of 32 liver samples represents the Rf + and Rf- treatments at four embryonic ages (e9, e11, e13, and e15),
with four biological replicates for each riboflavin treatment x age combination. Gross anatomy of Rf + and Rfembryos at e15 was documented using a Leica M420
macroscope (Buffalo Grove, IL) fitted with a Spot Insight
4 imaging system; images were taken at a magnification
of 10X.
Total RNA was extracted from each frozen liver sample using a RNeasy Mini kit (Qiagen, Valencia, CA), following the Qiagen protocol for the extraction of total
cellular RNA with minor modifications. The quantity of
the RNA was determined using a NanoDrop spectrophotometer (Wilmington, DE). RNA quality was analyzed by
microcapillary electrophoresis on an Agilent Bioanalyzer
2100 (Agilent Technologies, Wilmington, DE), where
the ribosomal RNA ratio (28S/18S) was assessed for
RNA integrity. The RNA was diluted to a standard

concentration (250 ng/μL). Liver RNA samples (1 μL
each) were loaded onto a RNA 6000 Nano Chip and analyzed. RNA with a RNA Integrity Number (RIN) between 9 and 10 indicated high quality and was used for
amplification of RNA.
RNA amplification and dye labeling

RNA amplification was performed with an Amino Allyl
MessageAmp™ II aRNA Amplification kit according to
the manufacturer’s protocol (Ambion; Austin, TX).
Briefly, a single round amplification of RNA was completed using 4 μg of total RNA. The in vitro transcription (IVT) reaction of amino allyl-modified RNA
(aRNA) was incubated for 14 h at 37 °C. The aRNA was
recovered, determined qualitatively with a RNA 6000
Nano Assay kit, and quantitatively with a NanoDrop
ND-1000 spectrophotometer prior to the aRNA/dye
coupling reaction. Twenty microgram of aRNA was
dried down to a minimal volume in a Savant Speed Vac,
reconstituted in 9 μL of coupling buffer and mixed with
11 μL of prepared dye [i.e., a 60 μg aliquot of either
Alexa Fluor® 555 or Alexa Fluor® 647 dye (Molecular
Probes, Inc. Eugene, OR) dissolved in DMSO]. A reference pool was made from an equal quantity of aRNA
from each of the 32 biological samples and multiple aliquots of reference aRNA labeled with Alexa Fluor® 647.
The 32 aRNA samples, representing two riboflavin treatment groups at 4 embryonic ages (Table 1), were individually labeled with Alexa Fluor® 555. Each labeled
target and reference aRNA sample was then purified on
a spin column, analyzed with a NanoDrop ND-1000
spectrophotometer, and dye incorporation determined.
Oligo microarrays and hybridization

The chicken long oligos were designed by ARKGenomics [22] from multiple chicken transcript databases. Chicken expressed sequence tags (ESTs) and transcript sequences were aligned and 70mer oligos
designed, using OligoArray2.0, against regions common
to more than one aligned sequence. The chicken oligo
set [Gallus gallus (chicken) Roslin/ARK CoRe Array
V1.0] was manufactured by Operon Technologies, Inc.

Table 1 Experimental Design
Embryonic age, day (e)

Riboflavin-rescued (Rf+) [n]

Riboflavin-deficient (Rf-) [n]

e9

8 (4 biological replicates)

8 (4 biological replicates)

e11

8 (4 biological replicates)

8 (4 biological replicates)

e13

4

4

e15

4

4

Fertile eggs, derived from riboflavin binding protein deficient (rd/rd) Single-comb White Leghorn (SCWL) chickens, were injected with riboflavin 5 phosphate
(FMN) [riboflavin-rescued (Rf+)] or saline [riboflavin-deficient (Rf-)] at the onset of incubation (e0). Eight viable embryos were killed for liver samples at e9 and e11,
while four viable embryos were killed for liver samples at e13 and e15. Two liver samples were randomly pooled to provide 4 biological replicates for each
treatment group at e9 and e11, while 4 individual livers samples represent biological replicates for each treatment group at e13 and e15. The very small size of
the liver in e9 and e11 required pooling of 2 livers to create each of the 4 biological replicates per riboflavin treatment group for the first two ages (e9 and e11).
Total RNA was purified from these 32 liver samples and used for both microarray analysis and qRT-PCR analysis
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(Alameda, CA). This chicken oligo set (Catalog #
851102) contains 20,460 long oligo probes (300 pmol)
arrayed in 54,384-well plates. For quality control, 4 wells
in each of the 54,384-well plates contained the Operon
Production Tracking Oligo opHsV04NC000001, which is
a randomly-generated oligo sequence with a length of 30
bases.
The “Arizona” 20.7 K chicken oligo arrays were
printed in a horizontal pattern by the Genomics Research Laboratory, Steele Children’s Research Center,
University of Arizona, (Tucson AZ). Each Arizona
20.7 K chicken oligo array, (NCBI GEO Platform
GPL6049) [23], was composed of 20,676 features that include 20,460 70mer oligos and 216 control spots of the
Operon Production Tracking Oligo opHsV04NC000001.
The oligos (300 pmol) were dissolved in 8 μL of 50%
DMSO for printing. The chicken oligo array was printed
in a horizontal pattern onto Corning® UltraGAPSTM
aminosilane coated slides (Cat # 40018) using a Virtek
ChipWriter Pro (Model # HCO1-M) robot fitted with 48
TeleChem (SMP2.5) pins in a HEPA-filtered positivepressure chamber maintained at 24 °C and 48% RH (± 2
%RH). The printed slides were dried overnight at room
temperature (22-25 °C with 20-40% RH). The slides were
then stored in a chemical (Drierite) desiccator at room
temperature until use.
The oligo microarrays were baked at 90 °C for 1 hour
prior to use. The arrays were pre-treated for 45 min at
42 °C in pre-hybridization solution containing 5× SSC,
0.1% SDS and 1% BSA and followed by dipping for
5 min in 2× SSC and then 0.2× SSC. The slides were
spin dried for 5 min at 1000 x g. Eight microgram of labeled aRNA was fragmented in 1× fragmentation buffer
(Ambion) for 15 min at 70 °C. The reaction was then
terminated by adding stop solution and dried down
(SpeedVac) to a minimal volume. Each labeled target
and reference RNA sample was reconstituted prior to
hybridization in a 30 μL volume of pre-warmed DIG
Easy Hyb solution (Roche Diagnostics Corporation; Indianapolis, IN). All reference samples were pooled together and aliquot into 30 μL. An equal amount (8 μg)
of target and reference samples were mixed with 2.5 μL
of 10 mg/ml yeast tRNA, 2.5 μL of 10 mg/ml salmon
testes DNA (Sigma, Louis, MO). The reference/target
mixture (65 μL) was denatured for 2 min at 94 °C,
cooled at room temperature, carefully loaded onto the
middle of a pre-treated microarray slide held in a
hybridization chamber (Corning #2551, Lowell, MA)
and overlaid with a 22 × 65 mm LifterSlip (Erie Scientific, Portsmouth, NH). The sealed hybridization chamber was incubated overnight (14-16 h) at 42 °C in a
water bath under a light-tight box. On the following day,
slides were sequentially washed with 1 x SSC, 0.2% SDS,
and 0.5% DTT at 42 °C for 10 min, then 0.1 x SSC, 0.2%
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SDS, and 0.5% DTT for 5 min at room temperature, and
finally 0.1 x SSC and 0.5% DTT for 1 min at room
temperature (with high-purity nitrogen gas bubbled
through each of the wash solutions to prevent interference by ozone). The slides were subsequently rinsed in
distilled water and dried by centrifugation. Before scanning, slides were stored in individual 50 ml tubes covered in aluminum foil and filled with nitrogen gas.
Microarray data analysis

The 32 amplified liver RNA samples were hybridized to
32 chicken long-oligo microarrays using a reference
RNA design and blocked on hybridization day (Day 1 or
Day 2); where, 32 microarray slides represented 4 biological replicates across 2 riboflavin treatments and 4
embryonic ages (Additional file 1). Liver amplified RNA
samples were labelled with Alexa Fluor™ 555 dye and an
aliquot of the reference RNA pool was labelled with
Alexa Fluor™ 647 dye. A GenePix 4000B scanner with
GenePix Pro 4.1 software (Molecular Devices, Union
City, CA) was used to scan hybridized slides at wavelengths of 532 nm for the Alexa Fluor™ 555-label and
635 nm for the Alexa Fluor™ 647-label. The scanner
laser power was set at 100% and the photomultiplier
tube (PMT) setting was adjusted to unity for each scan.
The GenePix software provided a combined TIFF image
file for each slide. The high-resolution image files were
first analyzed using GenePix Pro v4.1 software, without
correction for background. The GenePix report (gpr)
files were automatically merged with an annotated Excel
file containing the oligo identification [Roslin Institute
Gallus gallus (RIGG)] number and array metadata [24]
on our laboratory website [25] using the “Oligo Arrays”
function designed for the Arizona 20.7 K Chicken Oligo
Array (v2).
Normalization and statistical analysis of microarray data

Limma software was used for processing, normalization
and determination of differential gene expression [26].
Median intensities for each dye were Loess normalized
(without background subtraction) within array and between array to correct for dye and slide biases. The
Benjamini-Hochberg procedure [27] was used to control
the experiment-wise false discovery rate (FDR ≤ 0.05)
due to multiple testing procedures. Gene expression represents the log2 ratio of normalized dye ratios (Experimental aRNA/Reference aRNA). A gene was considered
differentially expressed (DE) if the log2 fold-change
(Alexa Fluor™ 555/Alexa Fluor™ 647 intensity ratio) was
significant as indicated by the adjusted p-value (P ≤ 0.05)
and FDR ≤ 0.05. The Limma output data were then statistically analyzed using a linear mixed model in the
Statistical Analysis System (SAS; Cary NC) [28, 29],
which we have described earlier [30, 31]. Mixed models
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were used to account for biological and technical variation (dye, day of hybridization) across the 32 oligo microarrays and to determine the main effects of riboflavin
treatment (Rf + verses Rf-) and embryonic age, and their
interaction. The DE gene lists derived from statistical
analyses were then submitted to Ingenuity® Pathway
Analysis for final annotation and functional analysis.
Ingenuity Pathway Analysis and Ingenuity Up-Stream
Regulator Analysis

The DE gene lists generated from statistical contrast
were used as input files for annotation and functional
analysis using Ingenuity® Pathway Analysis (IPA) [32].
Only DE genes with a NCBI Reference Sequence (RefSeq) Protein ID are accepted IPA as “Analysis Ready”
(AR) and imported into the online database for a “Core
Analysis”, which maps AR-DE genes to canonical pathways, biological processes and gene interaction networks
accrued in the Ingenuity® Knowledge Base, which is
largely mammalian concentric and devoid of annotated
avian-specific genes. The Ingenuity® Up-stream Regulator Analysis was used to identify major transcription factors, direct interaction with other upstream regulators,
and direct interactions with target genes to predict activation or inhibition of particular biological pathways and
processes. IPA uses the Fisher’s Exact Test to provide
significance (P ≤ 0.05) of over-representation of AR-DE
genes in canonical pathways and biological processes,
based on the probability that AR-DE genes are associated with a particular biological process or pathway.
Quantitative RT-PCR (qRT-PCR) analysis and verification of
differential gene expression

Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis was performed to verify select
gene expression patterns found by microarray analysis.
A total of 42 primers were designed using Primer Express v2.0 (Applied Biosystems, Foster City, CA). Details
of primer design including the Roslin Institute Gallus
gallus (RIGG) oligo ID number, gene symbol, forward
and reverse sequences, and amplicon size (bp) are provided (Additional file 2). First-strand cDNA synthesis
was completed using Superscript III reverse transcriptase (Invitrogen), an oligo (dT) primer, and 1 μg of purified total RNA. The qRT-PCR analysis was performed in
384-well plates containing 1 μL of cDNA template/well
and 5 μL of a super mix providing: 3 μL SYBR® Green
PCR Master Mix, 1.5 μL RNase-DNase free water and
0.5 μL of each primer (concentration 10 μM). A total of
eight plates were analyzed in an ABI Prism Sequence
Detection System (Model 7900HT), where the 384-well
plate format allowed duplicate wells for four primer sets
across the 24 candidate genes and a panel of 6 invariant
“housekeeping” genes, which were used for evaluation
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and normalization of qRT-PCR expression data. The
average cycle time (Ct) for each biological sample was
normalized to the geometric mean of the most stable
“housekeeping” genes using Biogazelle qbase+ [33] software. The most invariant genes (COX7A2L and PCF11)
identified by the geNorm software were used for
normalization and calculating relative transcript abundance, which was based on the 2ΔΔCt formula [34]. The
normalized qRT-PCR gene expression values from this
factorial design experiment [2 riboflavin treatments × 4
embryonic ages (e9-e15)] were then analyzed by twoway analysis-of-variance (ANOVA) using the general linear model (GLM) procedure in the Statistical Analysis
System (SAS; v9.3.1). The GLM procedure allowed determination of the significant (P ≤ 0.05) effects of riboflavin treatment, age, and their interaction. The protected
Fisher’s least significant difference (LSD) test was used
for mean separation. The Pearson’s Correlation Analysis
was completed using 21 DE “candidate” genes identified
by microarray analysis and the normalized expression
levels of these genes obtained by the qRT-PCR analysis
described above.
An additional qRT-PCR analysis was completed on 12
additional genes of special interest. The abundance of 12
additional genes was determined on an identical set of
32 RNA samples representing 4 biological samples/treatment (Rf + and Rf-) at 4 embryonic ages (e9, e11, e13
and e15). Relative transcript abundance was based on
the 2ΔΔCt formula [34] and normalized against a single
invariant gene (COX7A2L). These expression levels are
presented as arbitrary units (AU) and represent the
mean ± SEM of four embryos/riboflavin treatment
across 4 ages. The Student’s t-test was used to determine
significant (P ≤ 0.05) differences between Rf + and Rfembryos at each age.

Results
Gross anatomical features of riboflavin-deficient and
riboflavin-rescued chick embryos

Figure 1a shows the gross anatomy of typical riboflavindeficient (Rf-) and riboflavin-rescued (Rf+) chick embryos at e15. The mortality of riboflavin-deficient embryos increased sharply between e13 and e15, reaching
more than 75% by e15. The photo-macrographs show
the head of typical rd/rd embryos, with (Rf+) and without (Rf-) riboflavin supplementation, immediately after
their removal alive from the eggshell. Notable hallmarks
of riboflavin-deficiency in rd/rd chick embryos were retarded development of the head, eye, beak and feathers,
and extensive cutaneous hemorrhage (Fig. 1a). The liver
of the Rf- embryo shows massive hemorrhage and engorgement with yolk lipids along its perimeter. In contrast, the head of the Rf + embryo shows normal
development of the beak, head, eye and feathers.
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Likewise, the Rf + embryo presents with a pale yellowcolored liver, indicating normal lipid accumulation and
utilization of a normal chick embryo at e15.
Differentially expressed genes identified by microarray
analysis

There were no differentially expressed genes found between Rf- and Rf + embryos at e9 and e11. Therefore,
only the main effect of riboflavin treatment (at e13 and
e15) was considered for further functional analyses using
IPA. In contrast to the lack of DE genes at e9 and e11,
396 differentially expressed (DE; adjusted P ≤ 0.05 and
FDR ≤ 0.05) genes were identified in e13 embryos; while
1467 DE genes were found between Rf- and Rf + embryos at e15 (Additional file 3). [It should be noted that
the DE genes indicated above represent all DE oligo
spots identified by statistical analysis, whether or not the
RIGG oligo was annotated.] The reduced number of DE
hepatic genes accepted by IPA as “Analysis Ready” was
due to the lack of an annotation [NCBI Ref-Seq protein
ID] for 74 “unknown” RIGG oligos at e13. Likewise, another 248 DE “unknown” RIGG oligos identified at e15
were rejected by IPA from further functional analyses.
The last annotation of the chicken 20.7 K RIGG oligo
array was published in 2009 [24] with 23% of the RIGG
oligo IDs void of any annotation (i.e., unknown). Accordingly, this is similar to our observed rejection of
17% of DE RIGG oligos (248 genes) from our microarray
analysis of liver across both riboflavin-deficient (98
RIGG IDs rejected) and -rescued (149 RIGG IDs
rejected) embryos without a functional analysis by IPA.
Consequently, only 221 DE genes at e13 and 929 DE
genes at e15 were matched to annotated genes accrued
in the Ingenuity® Knowledge Base (Fig. 1b). Genes
mapped to NCBI Entrez IDs or Ref-Seq proteins accrued
in the Ingenuity® Knowledge Base are considered by IPA
as “Analysis Ready” and denoted as AR-DE genes in subsequent figures and tables. There were 59 unique AR-DE
genes at e13 and 767 unique AR-DE genes, whereas 162
AR-DE genes were commonly shared between e13 and
e15 embryos. The e13 and e15 AR-DE gene sets were
functionally annotated using the Core Analysis feature
in IPA software and the Ingenuity® Upstream Regulator
Analysis.
Ingenuity Pathway Analysis of AR-DE genes in liver of Rf
+ and Rf- embryos at e13

A summary of the IPA analysis of e13 embryos is presented in Table 2. The top five canonical pathways identified in liver of e13 embryos were “IL-8 Signaling, JAK/
Stat Signaling, EIF2 Signaling, RANK Signaling in Osteoclasts, and Proline Biosynthesis I”. Ingenuity Upstream
Regulators Analysis predicts that E2F transcription factor 1 (E2F1), MYC proto-oncogene, bHLH transcription
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factor (MYC), activating transcription factor 4 (ATF4),
transcription factor 3 (TCF3) and peroxisome proliferator activated receptor alpha (PPARA) were the major
transcriptional regulators of AR-DE genes found at e13.
The “Top Molecular and Cellular Functions” identified
by IPA at e13 were “Amino Acid Metabolism, Small
Molecule Biochemistry, Molecular Transport, Cell Cycle
and Cell Death/Survival”. The major divisions of the
“Physiological System Development and Function” category were related to function and development of the
endocrine, cardiovascular and digestive systems, whole
organism and organ morphology. Another category
identified by IPA was “Hepatotoxicity”, which included
several subdivisions (“Liver Proliferation, Steatosis, Fibrosis, Carcinoma, and Hyperplasia/Hyper-proliferation”). Among the top 10 genes that were expressed
higher in the liver of Rf + embryos at e13 were 3 coagulation factors [thrombin (F2), vitamin K-dependent coagulation factor IX (F9), and vitamin K-dependent
protein Z (PROZ). The top 10 over-expressed genes in
the liver of Rf- embryos at e13 were of a higher magnitude (log2-1.4 to − 2.7) than those of the Rf + embryos
and included ankyrin repeat domain 22 (ANKRD22),
ovochymase 2 (OVCH2), aldehyde dehydrogenase 18
family member A1 (ALDH18A1), carbonic anhydrase 2
(CA2), galectin 1 (LGALS1), retinol binding protein 7
(RBP7), pyrroline-5-carboxylate reductase family member 2 (PYCR2), perilipin 2 (PLIN2; which coats intracellular lipid droplets), and asparagine synthetase,
glutamine-hydrolyzing (ASNS). Interestingly, four of
these highly expressed hepatic genes found in Rf- embryos are involved in synthesis of several amino acids
(ALDH18A1, LGALS1, PYCR2 and ASNS).
Ingenuity Pathway Analysis of AR-DE genes in liver of Rf
+ and Rf- embryos at e15

The summary of IPA analysis of the 929 AR-DE genes
found in e15 embryos is presented in Table 3. The top
five canonical pathways populated by the AR-DE genes
on e15 were “EIF2 Signaling, Intrinsic Prothrombin Activation, LXR/RXR Activation, Tryptophan Degradation,
and Cholesterol Biosynthesis”. The “Top Molecular and
Cellular Functions” over-represented by AR-DE genes
were “Protein Synthesis” (139 genes), “Lipid Metabolism”
(173 genes), “Small Molecule Biochemistry” (212 genes),
“Amino Acid Metabolism” (47 genes), and “Vitamin and
Mineral Metabolism” (61 genes). The top five categories
under “Physiological System Development and Function”
were “Tissue Morphology, Organismal Development,
Connective Tissue Development and Function, Tissue
Development, and Digestive System Development and
Function”. The major sub-categories and direct target
genes under “Hepatotoxicity” were “Hepatocellular
Carcinoma”
(64
genes),
“Liver
Hyperplasia/
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Table 2 IPA summary of microarray analysis of liver in riboflavin-deficient chick embryos at e13
Top Canonical Pathways

p-value

Overlap

Ratio

IL-8 Signaling

3.85E-05

5.1%

10/197

JAK/Stat Signaling

2.14E-04

7.2%

6/83

EIF2 Signaling

4.85E-04

4.1%

9/221

RANK Signaling in Osteoclasts

6.17E-04

5.9%

6/101

Proline Biosynthesis I

6.22E-04

50.0%

2/4

Top Upstream Regulators
E2F1

p-value of overlap

# Target genes

3.40E-07

19

MYC

5.14E-07

30

ATF4

1.60E-06

10

TCF3

4.20E-06

12

PPARA

9.09E-06

16

Top Molecular and Cellular Functions

p-value

# Genes

Amino Acid Metabolism

1.03E-02 - 1.07E-07

22

Small Molecule Biochemistry

1.03E-02 - 1.07E-07

58

Molecular Transport

1.03E-02 - 5.02E-06

59

Cell Cycle

1.03E-02 - 8.67E-06

38

Cell Death and Survival

1.03E-02 - 5.35E-05

68

Physiological System Development and Function

p-value

# Genes

Endocrine System Development and Function

1.03E-02 - 5.02E-06

7

Organismal Development

1.03E-02 - 9.26E-06

64

Cardiovascular System Development and Function

8.81E-03 - 1.41E-05

31

Organ Morphology

1.03E-02 - 1.41E-05

40

Digestive System Development and Function

9.14E-03 - 1.74E-05

34

Hepatotoxicity

p-value

# Genes

Liver Proliferation

2.04E-02 - 8.34E-05

10

Liver Steatosis

4.45E-01 - 1.55E-03

11

Liver Fibrosis

3.91E-01 - 1.72E-03

9

Hepatocellular Carcinoma

2.28E-01 - 2.89E-03

19

Liver Hyperplasia/Hyper-proliferation

2.43E-01 - 2.89E-03

76

Top Up-regulated genes

log2 Rf+/Rf-

Top Down-regulated genes

log2 Rf+/Rf-

CHODL

1.41

ANKRD22

−2.74

FAM84A

1.27

OVCH2

−2.42

PROZ

1.24

EIF5B

−2.01

TOP1

1.21

ALDH18A1

−1.99

COMT

1.18

CA2

−1.97

F9

1.17

LGALS1

−1.77

RUFY2

1.17

RBP7

−1.75

GATM

1.14

PYCR2

−1.68

F2

1.09

PLIN2

−1.67

GC

1.07

ASNS

− 1.38

Ingenuity Pathway Analysis (IPA) of 221 “Analysis Ready” (AR) and differentially expressed (DE; FDR ≤ 0.05) (AR-DE) genes from riboflavin-rescued (Rf+) and
riboflavin-deficient (Rf-) chickens on embryonic day 13 (e13). P-values were determined by IPA using Fisher’s Exact Test and represent the likelihood that AR-DE
genes are over-represented and associated with a particular biological process or pathway. The percent overlap and ratios were calculated for the number of
observed AR genes compared to the number of known genes for that category represented in the Ingenuity® Knowledge Base
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Table 3 IPA summary of microarray analysis of liver in riboflavin-deficient chick embryos at e15
Top Canonical Pathways
EIF2 Signaling

p-value

Overlap

Ratio

9.53E-08

13.1%

29/221

Intrinsic Prothrombin Activation Pathway

1.99E-07

34.5%

10/29

LXR/RXR Activation

2.25E-07

16.5%

20/121

Tryptophan Degradation III

3.58E-07

37.5%

9/24

Super-pathway of Cholesterol Biosynthesis

1.62E-06

32.1%

9/28

Top Upstream Regulators

p-value of overlap

# Target genes

4.81E-14

161

MYC

5.70E-11

93

PPARA

1.34E-10

50

ESR1

5.09E-10

150

NFE2L2

9.70E-08

105

HNF4A

Top Molecular and Cellular Functions

p-value

# Genes

Protein Synthesis

2.61E-03 - 8.55E-11

139

Lipid Metabolism

3.08E-03 - 7.82E-10

173

Small Molecule Biochemistry

3.33E-03 - 7.82E-10

212

Amino Acid Metabolism

3.19E-03 - 4.41E-09

47

Vitamin and Mineral Metabolism

2.18E-03 - 7.36E-09

61

p-value

# Genes

3.00E-03 - 1.44E-06

131

Physiological System Development and Function
Tissue Morphology
Organismal Development

3.31E-03 - 1.84E-06

246

Connective Tissue Development and Function

2.92E-03 - 5.93E-06

158

Tissue Development

3.31E-03 - 5.93E-06

159

Digestive System Development and Function

1.85E-03 - 7.57E-06

77

p-value

# Genes

6.04E-01 - 9.22E-05

64

Hepatotoxicity
Hepatocellular Carcinoma
Liver Hyperplasia/Hyperproliferation

6.04E-01 - 9.22E-05

313

Liver Fibrosis

4.36E-01 - 2.50E-04

23

Liver Proliferation

4.60E-01 - 2.50E-04

24

Liver Necrosis/Cell Death

4.04E-01 - 1.85E-03

20

Top Up-regulated genes

log2 Rf+/Rf-

Top Down-regulated genes

log2 Rf+/Rf-

FKERa

3.43

HMGCS1

−3.61

AHSG

2.57

OVCH2

−2.61

SPINK5

2.38

ANKRD22

−2.58

ALB

2.27

HMGCL

−2.40

SLC13A3

2.21

LGALS1

−2.34

SERPINC1

2.17

RBP7

−2.09

ANGPTL3

2.14

ACAT2

−1.99

PLG

2.10

TPPP

−1.92

GATM

2.06

EIF5B

−1.78

NEBL

2.06

RPL22L1

−1.78

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 929 “Analysis Ready” (AR) and differentially expressed (DE; FDR ≤ 0.05) (AR-DE) genes from
riboflavin-rescued (Rf+) and riboflavin-deficient (Rf-) chickens on embryonic day 15 (e15)
a
Note: FKER was the highest expressed gene found in liver of Rf + embryos at e15 (see Additional file 3, Riboflavin_e15 worksheet). However, this avian-specific
gene was not annotated in the Ingenuity® Knowledge Base and therefore rejected by IPA
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Hyperproliferation” (313 genes), “Liver Fibrosis” (23
genes), “Liver Proliferation” (24 genes), and “Liver Necrosis/Cell Death” (20 genes). The 10 most highlyexpressed genes found in the liver of Rf + embryos at
e15 were feather keratin (FKER), alpha 2-HS glycoprotein (AHSG), serine peptidase inhibitor, Kazal type 5
(SPINK5; an inhibitor of thrombin), albumin (ALB), serpin family C member 1 (SERPINC1), angiopoietin like 3
(ANGPTL3), plasminogen (PLG), glycine amidinotransferase (GATM) and nebulette (NEBL). Among the 10
highest expressed genes in liver of Rf- embryos at e15
were 3-hydroxy-3-methylglutaryl-CoA synthase 1
(HMGCS1), ankyrin repeat domain 22 (ANKRD22), ovochymase 2 (OVCH2), 3-hydroxy-3-methylglutaryl-CoA
synthase 1 (HMGCL), 3-hydroxymethyl-3-methylglutaryl-CoA lyase (HMGCL), LGALS, RBP7, and acetyl-CoA
acetyltransferase 2 (ACAT2), which are involved in lipid
metabolism.
Detailed information on AR-DE genes that populate
major canonical pathways is provided in Additional file 4.
The eukaryotic translation initiation factor 2 (EIF2) Signaling Pathway contained 29 AR-DE genes (see Table 3);
and of these, only 3 AR-DE genes (ATF4, CCND1 and
BCL2) were expressed higher in the liver of Rf + embryos
whereas, 26 AR-DE genes (eukaryotic translation initiation factors and ribosomal proteins) genes were overexpressed in liver of Rf- embryos at e15. In contrast, 19
of the 20 AR-DE genes found in the LXR-RXR Activation Pathway, that controls lipid metabolism, were more
abundant in liver of Rf + embryos than Rf- embryos,
which had only a single up-regulated gene (CYP51A1),
which controls cholesterol biosynthesis. Farnesoid X receptor (FXR)-RXR Activation is another canonical pathway predominately populated by 17 AR-DE genes,
including AHSG, ALB, APOH and GC (or vitamin D
binding protein), that were expressed higher in the Rf +
embryos, compared to only a single gene (PPARG) that
was over-expressed in liver of Rf- embryos. Acute phase
response signaling, which provides a rapid non-specific
inflammatory response against infection, was also dominated by 17 AR-DE genes up-regulated in the Rf + embryo, compared to only 5 genes that were expressed
higher in liver of the Rf- embryos.
The “Intrinsic Prothrombin Activation” pathway in
IPA was over-represented by 10 AR-DE genes (SERPINC, F2, FGB, FGA, FGG, F9, COL3A1, COL2A1,
PROC and F13B), which were highly expressed in the Rf
+ embryos at e15. The IPA Blood Clotting mechanism
was over-represented by 23 highly-expressed AR-DE
genes in Rf + embryo whereas only two genes (PLA2G4A
and LGALS1) were over expressed in liver of Rf- embryos at e15. The highly expressed hemostasis genes
found in liver of the Rf + embryos include proteases
(CPB2, F2, F9, PLG) protease inhibitors (AGT,
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SERPINC1), collagen (COL14A1), clotting factors (FGA,
FGB, FGC, F13B) and cofactors (APOH, PROC, PROCZ).
Several of these clotting genes (ALB, AGT, APOH, PLG,
F2, FGA, FGB and FGG) are also involved in “Acute
Phase Response Signaling”.
“Fatty Acid Metabolism”, a sub-category under “Lipid
Metabolism” in IPA (Table 3) was over-represented by
66 AR-DE genes, where 45 AR-DE genes were highly
expressed in the Rf + liver and only 21 genes were
expressed at higher levels in the Rf- embryos (Additional file 5). Another sub-category under Lipid Metabolism was “Oxidation of Lipid”, which included 16 ARDE genes that were more abundant in the Rf- embryos,
compared to 7 genes expressed higher in the liver of Rfembryos. Also of interest was Carbohydrate (CHO) Metabolism, which was also overrepresented by 37 highlyexpressed AR-DE genes found in the Rf + embryos,
whereas only 19 genes associated with CHO metabolism
were expressed higher in liver of Rf- embryos. IPA
assigned 60 AR-DE genes to “Protein Catabolism”; and
of these, 39 genes were expressed at higher levels in the
Rf + embryo, while only 22 genes were associated with
catabolism of protein in the Rf- embryo, which have a
more active proteasome than do the Rf + embryos at
e15. “Metabolism of Amino Acids” (AA) was another
functional category of particular interest, where 16 ARDE genes were upregulated in the Rf + livers while 13
genes were upregulated in the Rf- embryos. Of the 20
AR-DE genes functionally annotated by IPA as “Protein
Ubiquitination”, only two genes were expressed higher
in liver of the Rf + embryos, whereas 18 genes were
expressed higher in the Rf- embryos.
Twelve AR-DE genes were assigned to metabolism of
vitamins with six genes upregulated in each riboflavin
treatment group. Furthermore, we mapped 95 homologs
of human flavoproteins onto the chicken genome sequence. And of these, 15 flavoprotein genes were
expressed higher in liver of Rf + at e15, which indicates
recovery; whereas only four of the DE genes were overexpressed in liver of Rf- embryos at e15, indicating global riboflavin deficiency.
Gene interaction networks generated from liver of Rf +
and Rf- embryos at e13 and e15

IPA annotated the gene interaction network depicted in
Fig. 2a as related to “Organismal Injury and Abnormalities, Hematological Disease”. Numerous coagulation
factors are overexpressed in the liver of Rf + embryos at
e15 as indicated in Table 3 and Additional file 4 (F2, F8,
F13B, FGA, FGB, FGG, PROC, PROZ, PLG, and VTN).
A more comprehensive list of DE (P ≤ 0.10) coagulation
genes is provided in Table 4, which shows 25 DE genes
that belong to “Blood Clotting” in the “BioFunction” category of IPA. Some of these coagulation factors directly
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a

b

Fig. 2 Two direct gene interaction networks identified by IPA in liver of Rf + and Rf- embryos at e15. The top panel (a) shows a gene interaction
network functionally annotated by IPA as involved in “Hematological Disease, Organismal Injury and Abnormalities”. The bottom panel (b) shows
a gene interaction network related to “Lipid Metabolism” and “Molecular Transport”. The legend indicates the major functional class of each gene.
Genes with red-colored symbols are expressed higher in liver of Rf + embryos at e15, whereas green-colored symbols indicate higher expression
in liver of Rf- embryos at e15

Cogburn et al. BMC Genomics (2018) 19:177
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Table 4 Twenty-five DE genes in liver of Rf + and Rf- embryos belonging to the blood coagulation/complement pathways

RIGG (Rosalind Institute Gallus gallus) oligo ID, gene symbol and description, and fold-change (Rf+/Rf- ratio) values are shown at two embryonic ages (e13 and
e15). A preliminary analysis with a relaxed significance level (P ≤ 0.10) was completed using GeneSpring GX software (Agilent Technologies; Santa Clara, CA).
Shaded expression values indicate higher expression of plasminogen activator inhibitor 1 (PAI-1) in liver of Rf- embryos

interact with genes (SPARC, ITGAV and HLF) that are
direct targets of Jun proto-oncogene, AP-1 transcription
factor subunit (JUN), which was up regulated in liver of
the Rf- embryo at e15. Most of these coagulation factors
are part of the “Intrinsic Prothrombin Activation” pathway, along with SERPINC1, COL3A1, COL2A1 and
PROC (Additional file 4). Only three additional targets
of JUN (ACAT2, FABP7 and SLC7A) were upregulated
in liver of Rf- embryos at e15. The remaining gene targets of JUN (DMTF1, Cyclin D, WTN9A, COMT,
BEND4, and BATF3) were expressed higher in liver of
Rf + than Rf- embryos. IPA functionally annotated the
second gene network (Fig. 2b) as related to “Lipid Metabolism” and “Molecular Transport”. Several genes involved in molecular transport or lipid metabolism
[APOH, APOD (or lipocalin), AMBP, POYOX1, AHSG,
GC, AGT, HSP90B1 and LIPC] were highly expressed in
liver of Rf + embryos at e15. These genes are centered
on high-density lipoprotein cholesterol (HDL). Additional lipolytic genes, up-regulated in the Rf + embryos,
were FKBP9, AADAC, LDAH, FAAH, PLA1A, MGLL,
PROC, TBX3 and GJA5. Only eight genes in this network
were expressed higher in the Rf- embryo liver
(PAFAH1B1, PLA2G4A, LYPLA2, PLA2R1 MIF AP1S3,
FAM49A and ABCD2).
The network in Fig. 3a shows direct interactions
among
four transcription
factors [peroxisome
proliferator-activated
receptor
gamma
(PPARG),
retinoid-activated receptor gamma (RXRG), nuclear receptor subfamily 1 group H member 4 or farnesolactivated receptor (NR1H4) or and nuclear receptor

subfamily 0 group B member 1 (NROB1)], which control
lipid metabolism. Three of these up-stream regulators
(RXRG, NR1H4 and NROB1) were up-regulated in liver
of Rf + embryos at e15, whereas PPARG was expressed
high in liver of the Rf- embryos. Five additional genes
(PLIN2, CYP3A4, HMGCS1, PEX7 and HMBS) were
higher in the Rf- embryo liver. The remaining genes,
highly expressed in Rf + embryo liver, are well-known
regulators of lipid metabolism [deiodinase 1 (DIO1),
angiopoietin like 3 (ANGPTL3), lipoprotein lipase (LPL),
acyl-CoA oxidase 2 (ACOX2), pyruvate dehydrogenase
kinase 4 (PDK4), acetyl-CoA acyltransferase 1 (ACAA1),
ELOVL fatty acid elongase 6 (ELOVL6), acyl-CoA synthetase long-chain family member 5 (ACSL5), and scavenger receptor class B member 2 (SCARB2)].
Ingenuity “Upstream Regulator Analysis” identified 30
AR-DE genes in Rf + and Rf- embryos at e15 that are
direct target of PPARG (Fig. 3b) and predicts that
PPARG should be activated (up-regulated) due to the
large number of up-regulated genes in the e15 dataset
(22 AR-DE genes). According to the Upstream Regulator
Analysis, the orange-colored gene symbol for PPARG indicates that it should be activated, which would lead to
up-regulation (orange arrows) of 22 direct target genes.
However, PPARG was highly expressed in the liver of Rfembryos as indicated by both microarray and qRT-PCR
analyses. Eight gene targets of PPARG were expressed at
higher levels in the Rf- liver at e15, including carbonic
anhydrase 2 (CA2), PLIN2, ornithine decarboxylase 1
(ODC1), enolase 2 (ENO2), aldehyde dehydrogenase 1
family member A2 (ALD1A2), Jun proto-oncogene
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a

b

Fig. 3 A gene network found in liver of e15 embryos showing direct interactions of ligand-activated nuclear receptors and their direct target
genes controlling “Lipid Metabolism” and “Molecular Transport” (a). Panel b shows the peroxisome proliferator activated receptor gamma (PPARG),
itself an auto-regulated gene and 30 direct target genes identified by the Ingenuity® Knowledge Base. IPA predicts, according to accrued
mammalian literature, that activated PPARG would lead to either activation (orange arrows) or inhibition (blunt blue edges) of its direct (AR-DE)
target genes

(JUN), malate dehydrogenase 1 (MDH1) and ribosomal
protein SA (RPSA).
A gene network centered on the interaction of JUN,
which is upregulated in Rf- embryos, with three other
upstream regulators [thyroid hormone receptor beta
(THRB), cyclin D1 and D2 (CCND1 and CCND2) is involved in “Cellular Growth and Proliferation” (Fig. 4a).

This gene network was identified by IPA from a combined dataset of all AR-DE genes found in the liver at
e13 and e15. Eight additional genes, expressed higher in
the liver of Rf- embryos, were serum/glucocorticoid regulated kinase 1 (SGK1), isoleucyl-tRNA synthetase
(IARS), baculoviral IAP repeat containing 2 (BIRC2; an
inhibitor of apoptosis), solute carrier family 7 member 1

Cogburn et al. BMC Genomics (2018) 19:177
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a

b

Fig. 4 A gene interaction network involving several upstream regulators and their direct target genes involved in “Cellular Growth and Proliferation”
(a). Ingenuity® Up-stream Regulator Analysis predicts activation of two transcription factors, JUN proto-oncogene, AP-1 transcription factor subunit
(JUN) and thyroid hormone receptor beta (THRB), and their direct target genes (b). These gene networks were identified in a combined dataset of all
AR-DE genes found in the liver at e13 and e15 (see Fig. 2b). The target genes were either upregulated in riboflavin-rescued (Rf+; red-colored symbols)
or expressed higher in riboflavin-deficient (Rf-; green-colored symbols) embryo livers. IPA predicts that the two up-stream regulators are “activated”,
which would lead to either activation (orange arrows) or inhibition (blunt blue edges) of their respective direct target genes

(SLC7A1), aminoacyl-tRNA hydrolase (PTH1), solute
carrier family 19 member 1 (SLC19A1; a folate transporter), asparagine synthetase (glutamine-hydrolyzing)
(ASNS) and epiregulin (EREG). Among the other upregulated genes in the Rf + embryos found in this network were N-myc downstream regulated 1 (NDRG1),
catechol-O-methyltransferase (COMT), epithelial cell adhesion molecule (EPCAM), high mobility group box 2

(HMGB2), and phenazine biosynthesis like protein domain containing (PBLD). Ingenuity Upstream Regulator
Analysis identified direct targets of the transcription factors JUN and THRB (Fig. 4b). Based on the observed
state of direct targets of JUN, Ingenuity predicts that
JUN should be activated, leading to activation of
IGFBP2, SPARC, WNT9A, CCND1, CCND2 and DMTF1
(orange-colored arrows). Blue-colored blunted lines

Cogburn et al. BMC Genomics (2018) 19:177

predict that JUN would inhibit expression of BIRC2,
FABP7, PTX3 and SNRPB2 (i.e., actually JUN and these
target genes are expressed higher in liver of Rf- embryos). Of the 17 targets of THRB, the majority (13 ARDE genes) are upregulated in liver of the Rf + embryos.
Further, activation of THRB in the Rf + embryos would
lead to downregulation of JUN (blunted blue line), which
is the observed state of JUN in the e15 dataset.
The gene network shown in Fig. 5a was annotated by
IPA as related to “Cell Death and Survival”. Eleven
genes were expressed higher in Rf + embryos at e15 including the transcription factor forkhead box O1
(FOXO1), solute carrier family 16 member 1 (SLC16A1;
a monocarboxylate transporter), tumor necrosis factor
superfamily member 10 (TNFSF10), ADP ribosylation
factor like GTPase 6 interacting protein 1 (ARL6IP1),
MAX dimerization protein 4 (MAXD4), sepiapterin reductase (SPR; or 7,8-dihydrobiopterin:NADP+ oxidoreductase), RAB11B, member RAS oncogene family
(RAB11B), optineurin (OPTN), microtubule associated
protein 1 light chain 3 alpha and beta (MAP1LC3A and
MAP1LC3B), and RAB GTPase activating protein 1 like
(RABGAP1L). We found higher expression of several
genes in liver of Rf- embryos, including tryptophan 2,3dioxygenase (TDO2), the flavoprotein, apoptosis inducing factor, mitochondria associated 2 (AIFM2), NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8),
baculoviral IAP repeat containing 2 (BIRC2), 3hydroxymethyl-3-methylglutaryl-CoA lyase (HMGCL),
diablo IAP-binding mitochondrial protein (DIABLO),
nuclear factor, interleukin 3 regulated (NFIL3),
RAB33B, member RAS oncogene family (RAB33B),
tyrosyl-tRNA synthetase (YARS), folliculin (FLCN),
receptor interacting serine/threonine kinase 1 (RIPK1),
CASP2 and RIPK1 domain containing adaptor with
death domain (CRADD), hook microtubule tethering
protein 1 (HOOK1) and ornithine decarboxylase 1
(ODC1). The network shown in Fig. 5b was functionally
annotated as “Cancer” and “Cell Cycle”. Three transcription factors, thyroid hormone receptor, beta
(THRB), paired like homeodomain 2 (PITX2) and
activating transcription factor 4 (ATF4) were expressed
at higher levels in Rf + embryos at e15, while early
growth response 1 (EGR1), core-binding factor beta
subunit (CBFB) and LIM domain binding 1 (LDB1)
were higher in liver of the Rf- embryos. Also upregulated in the Rf- embryos were solute carrier family 25
member 37 (SLC25A37), endothelin converting enzyme
2 (ECE2), importin 7 (IPO7), UDP-GlcNAc:betaGal
beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2;
which is involved in hepatocarcinoma), stanniocalcin 2
(STC2), solute carrier family 7 member 5 (SLC7A5) and
the anticancer gene, phosphoserine aminotransferase 1
(PSAT1).
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The gene network shown in Fig. 6a is involved in “Gene
Expression and Protein Synthesis” and focused on BCL2,
apoptosis regulator (BCL2), expressed higher in Rf + embryos at e15. Ten additional genes that interact with BCL2
and are highly expressed in Rf + embryos, include the
antioxidant peroxiredoxin 3 (PRDX3), collagen type XIV
alpha 1 chain (COL14A1), cathepsin V (CTSV), DLC1 Rho
GTPase activating protein (DLC1), L-2-hydroxyglutarate
dehydrogenase (L2HGDH), retinol saturase (RESTAT),
integral membrane protein 2B (ITM2B), dolichyldiphosphooligosaccharide–protein glycosyltransferase noncatalytic subunit (DDOST), calcineurin (PPP3CA), and myozenin 1 (MYOZ1). BCL2 also interacts with several genes
expressed higher in the Rf- embryos [caspase (CASP3), leucine aminopeptidase 3 (LAP3), mitochondrial ribosomal
protein L41 (MRPL41), translocase of outer mitochondrial
membrane 20 (TOMM20), ubiquinol-cytochrome c reductase complex assembly factor 1 (UQCC1) and three adenine
transporters (SLCC25A3, SLC25A4 and SLC25A6). Additional genes found up regulated in the Rf- embryos were:
ATP binding cassette subfamily B member 7 (ABCB7), ATP
binding cassette subfamily E member 1 (ABCE1), BCL2 like
13 (BCL2L13), ceramide synthase 6 (CERS6), eukaryotic
translation initiation factor 3, subunits D, I and M (EIF3D,
EIF3I, EIF3M), and ubiquitin specific peptidase 3 (USP3).
Whereas, coproporphyrinogen oxidase (CPOX), chromosome 14 open reading frame 159 (C14orf159), and family
with sequence similarity 96 member B (FAM96B) were
expressed higher in the Rf + embryos. According to IPA, the
network in Fig. 6b is related to “Developmental Disorder”
and “Metabolic Disease”. This network was composed of
direct targets of the up-regulated glucocorticoid receptor
(GCR; NR3C1) and their interaction with mitochondrial
complexes namely, subunits of cytochrome oxidase and
NADH: ubiquinone oxidoreductase, which with the exception of mitochondrial encoded cytochrome c oxidase I (MTCO1) were expressed higher in liver of the Rf- embryos.
Additional genes expressed higher in the Rf- embryos were
MED30, PTRH2, mind-bomb E3 ubiquitin protein ligase
(MIB2), MAT1A, MFSD2A, YAE1D1, SLC25A33, SLC38A1,
PDCD2 and IP6K3. The following genes were up regulated
in Rf + embryos: WDR3, prostaglandin reductase 1 (PTGR1),
COQ8A, CARD10, DNASE1L3, DPP7, IGFALS and CHP1.
The network shown in Fig. 7a is composed of several
phosphatases that are involved in “Carbohydrate Metabolism” and “Post-Translational Modification”. This gene
network was identified in a combined dataset of all ARDE genes found in the liver at e13 and e15. Several
phosphorylases, including glycogen phosphorylase L
(PYGL), protein phosphatase 1 regulatory subunit 3B
(PPP1R3B) and 3C (PPP1R3C), protein phosphatase 2
regulatory subunit B-alpha (PPP2R5A), protein tyrosine
phosphatase, receptor type R (PTPRR), inositoltetrakisphosphate 1-kinase (ITPK1), and dual specificity
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Fig. 5 Two direct gene interaction networks regulating apoptosis, necrosis and the cell cycle. The top panel (a) shows a gene network functionally
annotated by IPA as “Cell Death and Survival”, “Cell Morphology”. The bottom panel (b) depicts a gene network that was annotated by IPA as related
to the “Cell Cycle” and “Cancer”. These interaction networks were found in the liver of riboflavin-deficient and riboflavin-rescued embryos at e15

phosphatase 14 (DUSP14), and sphingosine-1-phosphate
phosphatase 2 (SGPP2) were expressed higher in liver of
Rf + embryos. Other up-regulated genes in the Rf + embryos include PX domain containing 1 (PXDC1), torsin
1A interacting protein 1 (TOR1AIP1), RAB GTPase activating protein 1 like (RABGAP1L), and the serotonin
transporter (SLC6A4). Sixteen additional genes in this
network are expressed higher in Rf- embryos including

(PEX10), S1 RNA binding domain 1 (SRBD1), lysophospholipase like 1 (LYPLAL1), SS18 like 2 (SS18L2), N-6
adenine-specific DNA methyltransferase 1 (N6AMT1),
protein phosphatase 2 catalytic subunit alpha (PPP2CA),
protein phosphatase 2 regulatory subunit B’alpha
(PPP2R2A), tyrosyl-tRNA synthetase (YARS), EYA transcriptional coactivator and phosphatase 3 (EYA3), protein tyrosine phosphatase, non-receptor type 2 (PTPN2),
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Fig. 6 Two interaction networks found in the liver of riboflavin-deficient and riboflavin-rescued embryos at e15. The top panel (a) depicts a direct
gene interaction network involved in “Gene Expression” and “Protein Synthesis”. This gene network illustrates direct interactions of the apoptosis
regulator BCL2 with numerous enzymes and transporters. The bottom panel (b) shows the glucocorticoid receptor (GCR) [or NR3C1] and several
direct target genes; two of which (MED30 and COQ8A) interact with subunits of mitochondrial cytochrome c oxidase (COX) and NADH:ubiquinone
oxidoreductase (NDUF). This network was annotated by IPA as related to “Developmental Disorder” and “Metabolic Disease”

dual specificity phosphatase 12 (DUSP12), 3hydroxyacyl-CoA dehydratase 2 (HACD2), ubiquitin like
domain containing CTD phosphatase 1 (UBLCP1), nudix
hydrolase 6 (NUDT6), coiled-coil domain containing 51
(CCDC51) and OTU deubiquitinase with linear linkage
specificity (OTULIN).
The gene network in Fig. 7b is composed of several aldehyde dehydrogenases (ALDH8A1, ALDH9A, ALDH3A2
and ALDH1A2) and acyl-CoA dehydrogenases (ACAD11,

ACADL and ACAD8); according to IPA, these genes are
involved in “Lipid Metabolism and Small Molecule Biochemistry”. The short-chain dehydrogenase/reductase 4
(DHRS4) was expressed higher in the Rf + embryos,
whereas the retinol binding protein 1 (RBP1 or CRBP)
and ALDH1A2, which catalyzes the synthesis of retinoic
acid (RA), were more abundant in liver of the Rf- embryo
on e15. Additional up-regulated genes found in the Rf +
embryo include fibulin 5 (FBLN5), growth factor
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Fig. 7 Hepatic gene interaction networks involved in phosphorylation or retinal metabolism of riboflavin-deficient and riboflavin-rescued embryos. Panel a
shows the interaction of several phosphatases and phosphorylases, including glycogen phosphorylase (PYGL) and annotated by IPA as “Carbohydrate
Metabolism” and “Post-Translational Modification”. This gene network was identified in the combined dataset of all AR-DE genes found at e13 and e15.
The second gene network (b), found in liver of e15 embryos was composed mainly of acyl-CoA and aldehyde dehydrogenases, and functionally annotated
by IPA as involved in “Lipid Metabolism” and “Small Molecule Biochemistry”

independent 1B transcriptional repressor (GFI1B), ANKH
inorganic pyrophosphate transport regulator (ANKH),
fructose transporter (SLC2A5), albumen (ALB), diacylglycerol kinase gamma (DGKG) and midkine (neurite growthpromoting factor 2; MDK). Nine additional genes in this

network (RNH1, CSDE1, PLEKHA3, EPS15, CAPZA1,
GJA1, RPSA, UTP23 and P4HA1) were expressed higher
in liver of Rf- embryos at e15.
The gene network in Fig. 8a shows the interaction of proteasome subunits (PSMA4, PSMA6, PSMA7 and PSMG1)
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Fig. 8 Gene interaction networks controlling the proteasome (a) and cell signaling via G-protein coupled receptors (b) in liver of riboflavin-deficient
and riboflavin-rescued embryos at e15. Panel a shows interactions between components of the proteasome and direct target genes of cyclin D
(CCND1) and annotated by IPA as “Neurological Disease”. The gene network in Panel b depicts interactions of several G-protein coupled receptors
(GPCRs) and members of the tublin complex. This network was functionally annotated by IPA as related to “Hematological Disease” and
“Cell Signaling”

with the transcription factor cyclin D1 (CCND1) and its
direct targets in liver of e15 embryos. The expression of
CCND1, F-box protein 7 (FBXO7), CCND2, BMP/retinoic

acid inducible neural specific 1 (BRINP1), mesoderm development candidate 2 (MESDC2), transmembrane anterior
posterior transformation 1 (TAPT1) and phenazine
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biosynthesis like protein domain containing (PBLD) were
up regulated in liver of Rf + embryos. Among genes that
were expressed higher in the Rf- liver and directly related
to CCND1 were ring-box 1 (RBX1), 7-dehydrocholesterol
reductase (DHCR7), F-box and WD repeat domain containing 8 (FBXW8), thyroid hormone receptor interactor 13
(TRIP13), mitochondrial fission regulator 2 (MTFR2), kinetochore complex component (SPC25), and CCNG1. Additional genes expressed higher in the Rf- embryo were the
riboflavin transport protein solute carrier family 52 member 3 (SLC52A3), TBC/LysM-associated domain containing
1 (TLDC1), programmed cell death 5 (PDCD5), sorting
nexin 7 (SNX7), and testis expressed 11 (TEX11). IPA functionally annotated the gene network in Fig. 8b as related to
“Hematological Disease and Cell Signaling”. This network
is composed of a cluster of G-protein coupled receptors
(GCPRs), including adenosine A2b receptor (ADORA2B),
purinergic receptor P2Y10 (P2RY10), G protein-coupled receptor 146 (GPR146), frizzled class receptor 2 (FZD2),
FZD4, corticotropin releasing hormone receptor 2
(CRHR2), G protein-coupled receptor class C group 5
member C (GPRC5C), endothelin receptor type B
(EDNRB), and guanine nucleotide binding protein (G protein), alpha inhibiting-2 and -3 (GNAI2 and GNAI3). All of
these genes, except P2RY10, were expressed higher in Rf +
embryos. The tubulin cluster [tubulin beta 1 (TUBB1)] interacts G protein alpha, prefoldin subunit 1 (PFDN1), guanine deaminase (GDA), malate dehydrogenase 1 (MDH1),
via H3 domain containing GRB2 like, endophilin B1
(SH3GLB1), and enolase (ENO), which are all expressed at
higher abundance in Rf- embryos at e15. Interestingly, serpin family C member 1 (SERPINC1 or anti-thrombin 3),
gephyrin (GPHN], protocadherin 18 (PCDH18) and ubiquitin like 7 (UBL7) were up-regulated DE genes in the Rf +
embryos.
Verification of differential gene expression in Rf + and Rfembryos by qRT-PCR analysis

Twenty-four “candidate” genes were initially selected
based on biological function for verification of differential expression by qRT-PCR analysis across four embryonic ages (e9, e11, e13 and e15), along with 6 invarant
housekeeping genes (see Additional file 2). The qRTPCR analysis was performed on the same 32 RNA samples that were used for the microarray analysis. As found
in microarray analysis, qRT-PCR analysis showed no significant differences in expression of eight metabolic
genes between the Rf + and Rf- embryos at e9 or e11
(Fig. 9). The expression of ACAA1, ACADL, ELOVL6,
HSD11B1 and monoacylglycerol O-acyltransferase 1
(MOGAT1) was higher in liver of Rf + embryos at e15.
On the other hand, the abundance of the hepatic FABP1
and the ketogenic enzyme HMGCL was greater in liver
of the Rf- embryos at e13 and e15.
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The greatest differences in expression of six
hemostasis genes (Fig. 10) were found between Rf + and
Rf- embryos at e15, where Rf- embryos had a lower
abundance as indicated by a significant (P ≤ 0.01-P ≤
0.001) main effect of riboflavin treatment (T) or a treatment by age (T x A) interaction (F2, F9, SERPINC1, SERPIND1 and PLG). The expression of apolipoprotein A5
(APOA5), which controls plasma triglyceride levels, was
3-fold higher in the liver of Rf- embryos at e13 and e15.
The APOH transcript was more abundant in liver of Rf
+ embryos at e13 and e15, as indicated by a highly significant (P ≤ 0.001) treatment x age interaction.
The expression of six hepatic genes [frizzled homolog
2 (FZD2), feather keratin (FKER), pyruvate dehydrogenase kinase, isozyme 4 (PDK4), serum/glucocorticoid regulated kinase 2 (SGK2), TNF-related apoptosis inducing
ligand-like (TRAIL-LIKE) and phospholipase A1 member
A (PLA1A) was higher in Rf + embryos at e13 and e15
(Fig. 11). Remarkably, the abundance of feather keratin
(FKER) was 100-times greater in liver of Rf + embryos at
e15 than that found in Rf- embryos. In contrast, the expression of the antimicrobial peptide β-defensin 9
(DEFB9) and acetyl-CoA acetyltransferase 2 (ACAT2)
were 2-fold to 3-fold greater in liver of the Rf- embryos
between e13 and e15.
An additional qRT-PCR analysis was completed on
12 genes of special interest (Fig. 12). In this case, significant differences (P < 0.05) between riboflavin treatments at each age were determined by the Student’s
T-test. The expression of peroxisome proliferator activated receptor alpha (PPARA) was higher in the Rf +
embryos at e15, while PPARG levels were sharply elevated in liver of the Rf- embryos at e13 and e15. In
contrast, the hepatic expression of PPARD was not affected by riboflavin availability or embryonic age. The
abundance of medium chain acyl-CoA dehydrogenase
(MCAD) was lower in Rf- embryos at e15. The expression of high-density lipoprotein binding protein
(HDLBP),
perilipin
2
(PLIN2)
[or
adipose
differentiation-related protein (ADRP)], ubiquilin 1
(UBQLN1) and the apoptosis inducer caspase 3
(CASP3) were also higher in the Rf- embryos at e13
and e15. Porimin (PORIMIN) transcript levels were
significantly higher in the Rf- embryos at e11, e13
and e15. Porimin is a unique cell surface receptor
that mediates oncotic cell death, characterized by rupture of the cell membrane without DNA fragmentation. Serine peptidase inhibitor, Kazal type 5 (SPINK5)
[or ovoinhibitor (OIH)] expression increased progressively in liver of the Rf + embryo and reached highest
levels (P ≤ 0.05) at e13 and e15. The pattern of phosphoserine phosphatase (PSPH) expression was similar
to that of PLIN2, being sharply up-regulated in liver
of Rf- embryos between e13 and e15. Betaine-
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Fig. 9 Verification of differential expression of eight metabolic genes in liver of riboflavin-deficient chick embryos by qRT-PCR analysis. The abundance of
eight metabolic genes was determined in 4 biological samples/treatment (Rf + or Rf-) at 4 embryonic ages (e9, e11, e13 and e15). Data were analyzed by
ANOVA using the GLM procedure in SAS and mean separation using a protected Fisher’s least significant difference (LSD) test. The shaded insets show the
common standard error (SE) of the least squares mean (LSMEAN) and significant differences (* P ≤ 0.05, ** P ≤ 0.01 or *** P ≤ 0.001) for the main effects of
treatment (T) and age (A) or their interaction (T x A)

homocysteine S-methyltransferase (BHMT) transcript
abundance was consistently lower in liver of Rf- embryos, reaching significance at e9 and e13.
For verification of differential gene expression, the
Pearson’s correlation coefficient [r] was determined for
21 “candidate” genes using normalized expression values
(log2 ratio of Rf+/Rf-) averaged across two ages (e13 and
e15) from the qRT-PCR analysis versus the 20.7 K oligo
microarray analysis (Additional file 6). The calculated
Pearson’s coefficient (r = 0.834) from this data set indicates a highly significant (P ≤ 0.01) association between
normalized expression values determined by microarray
analysis and qRT-PCR analysis, as we have shown previously [30, 31].

Discussion
Previously, we have shown diminished activity of several
flavin-dependent enzymes in riboflavin-deficient chicken
embryos, disruption of fatty acid oxidation, alternative
energy production, hypoglycemia, and sudden death in
mid-embryonation [9, 10, 14, 16, 35, 36]. In the present
paper, we describe time-course (e9-e15) transcriptional
responses of liver in riboflavin-deficient and riboflavinrescued embryos. The general disruption of β-oxidation
of fatty acid causes excessive accumulation of lipid in
liver of riboflavin-deficient embryos (see Fig. 1a), as
reflected by higher expression of genes involved in adipogenesis and intracellular lipid storage (PPARG,
APOA5, PLIN2, DEFB9 and CYP51A1). Blood
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Fig. 10 Verification of differential gene expression in riboflavin deficient chick embryos by qRT-PCR analysis. The hepatic abundance of six coagulation
factors (F2, F9, SERPINC1, SERPIND1, AGT and PLG) and two lipid transporters (APOA5 and APOH) was determined in 4 biological samples/treatment
(Rf + or Rf-) at 4 embryonic ages (e9, e11, e13 and e15). Data were analyzed by ANOVA using the GLM procedure in SAS and mean separation using
Fisher’s protected least significant difference (LSD) test. The shaded insets show the common standard error (SE) of the least squares mean (LSMEAN)
and significant differences (* P ≤ 0.05, ** P ≤ 0.01 or *** P ≤ 0.001) for the main effects of treatment (T) and age (A) or their interaction (T x A)

coagulation factors were among the most highlyexpressed genes found in liver of riboflavin-rescued embryos, particularly genes belonging to the “Intrinsic Prothrombin Activation” cascade. A more extensive and
inclusive cluster of 25 hemostasis/clotting genes (see
Table 4) was revealed by our initial analysis of all 32 microarrays representing four riboflavin-deficient and four
riboflavin-rescued embryos across four embryonic ages
(e9-e15). Twenty-four genes belonging to the blood coagulation/complement pathway were expressed at higher
abundance in liver of riboflavin-rescued embryos at e13
and e15. The only exception was over-expression of a
single gene SERPINE2 (or plasminogen activator

inhibitor 1, PAI-1) in liver of the riboflavin-deficient embryos at e13 and e15. Plasminogen activator inhibitor 1
belongs to the fibrinolytic pathway which dissolves the
fibrin embedded in the blood clot. This suggests that increased hepatic expression of PAI-1 in riboflavindeficient embryos represents an attempt to prevent
blood loss, while faced with a failed coagulation system
at multiple levels. In riboflavin-deficient embryos, higher
expression of hepatic genes that enhance protein breakdown via activation of the ubiquitin-proteome pathway
eventually leads to apoptosis and programmed cell
death. Our present transcriptional study of riboflavindeficient and riboflavin-rescued embryos clearly shows
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Fig. 11 Verification of differential expression of eight DE genes in riboflavin deficient and rescued embryos by qRT-PCR analysis. The hepatic expression of
eight DE genes was verified by independent qRT-PCR analysis of the same RNA sample used in microarray analysis. The eight genes include frizzled class
receptor 2 (FZD2), feather keratin (FKER), defensin beta 9 (DEFB9), kinases (PDK4, SGK2), a phosphatase (PSPH), acetyl-CoA acetyltransferase 2 (ACAT2), and
phospholipase A1 member A (PLA1A). Data were analyzed by ANOVA using the GLM procedure in SAS and mean separation using Fisher’s protected least
significant difference (LSD) test. The shaded insets show the common standard error (SE) of least squares mean (LSMEAN) and significant differences
(* P ≤ 0.05, ** P ≤ 0.01 or *** P ≤ 0.001) for the main effects of treatment (T) and age (A) or their interaction (T x A)

the importance of a single required vitamin—riboflavin—across multiple critical biological processes (β-oxidation of lipid, euglycemia, blood coagulation and
feathering).
Riboflavin deficiency and impaired lipid metabolism

The most obvious difference in metabolism between Rfdeficient and Rf-rescued embryos was the excessive accumulation of lipid (see Fig. 1a) and intermediates of
fatty acid oxidation in liver of the Rf- embryos [16]. The
natural surge in lipid transfer from yolk to the liver in
mid-embryonic development [6, 37] is reflected by a
metabolic shift toward exclusive oxidation of lipid as

indicated by a respiratory quotient of 0.72 [15] until the
chick hatches and consumes its first meal. Among biological pathways that had notable differences in differential expression in genes were those of lipid metabolism,
where two-thirds of the 66 AR-DE genes were expressed
higher in the Rf + embryos (Additional file 5). Fatty acid
binding protein 1 (FABP1) and fatty acid binding protein
7 (FABP7) were expressed higher in liver of the Rf- embryos at e15. These genes belong to a family of cytoplasmic hydrophobic ligand-binding proteins, which are
involved in binding and intracellular transport of longchain fatty acids. In the heart and brain, FABP7 is
thought to be involved in regulating the supply of fatty
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Fig. 12 The hepatic expression of 12 additional “candidate” genes was examined by qRT-PCR analysis in riboflavin-deficient and riboflavin-rescued
embryos. The abundance of 12 additional genes was determined in an identical set of 32 RNA samples representing 4 biological samples/treatment (Rf
+ or Rf-) at 4 embryonic ages (e9, e11, e13 and e15). These gene expression levels are presented as arbitrary units (AU) and represent the mean ± SEM of
four embryos/treatment and age. The Student’s t-test was used at each age to determine significant differences (P ≤ 0.05) between Rf + and Rf- embryos

acids for mitochondrial β-oxidation [38]. Perilipin
(PLIN2) is found in the vascularized yolk sac of the
chick embryo [39] and associated with accumulation of
lipid droplets in cells, particularly adipocytes. A number
of genes encoding enzymes involved in recycling Coenzyme A (CoA) were more abundant in liver of Rf + embryos, including acyl-CoA synthase medium-chain 3
(ACSM3), acyl-CoA dehydrogenase, long chain (ACADL)
and acetyl-CoA acyltransferase 1 (ACAA1). In contrast,
the liver of Rf- embryos have higher expression of
acetyl-CoA acetyltransferase 2 (ACAT2) and genes that
drive ketogenesis [3-hydroxymethyl-3-methylglutarylCoA lyase (HMGCL) and 3-hydroxy-3-methylglutarylCoA synthase 1 (HMGCS1)], which were among the
most highly expressed genes found in the Rf- embryo at
e15. Thus, riboflavin deficiency in chicken embryos has
a great impact on β-oxidation, since it involves three

successive flavin-dependent enzymes [14]. We found a
depression in medium chain acyl-CoA dehydrogenase
(MCAD) transcripts in the riboflavin-deficient chick embryos. In humans, MCAD deficiency (MCDD) leads to
sudden death of breast-feeding infants, especially following a prolonged overnight fast [18]. Although Rf- embryos also experience sudden death [14], the etiology in
rd/rd embryos reflects the global impact of flavin deficiency, rather that deficiency of a single flavindependent enzyme [i.e., MCAD or acyl-CoA dehydrogenase (ACADM)]. Furthermore, the constraints of embryonic development within the cleidoic egg of amniotes
require a specialized transport system, the riboflavin
binding protein (RBP), to transport essential riboflavin
from the dam’s liver to the oviduct for deposition into
the fertilized egg. However, the rd/rd genotype does not
affect the intestinal riboflavin transport system, since
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both parents and hatchling chicks with this genotype receive an adequate supply of essential riboflavin (Vitamin
B2) from their respective diets for normal growth and
development.
Two ligand-activated nuclear receptor pathways were
overpopulated by AR-DE genes in liver of Rf + embryos
[“LXR-RXR (19/1) and FXR-RXR (17/1) Activation Pathways”]. The LXR is the major regulator of lipogenesis in
chicken liver, controlling lipogenic transcription factors
and lipogenic enzymes [40]. Farnesoid X receptor (FXR)
is a ligand-activated nuclear receptor that serves as a receptor for bile acids and a heterologous partner with
RXR. Mutations in the FXR gene lead to familial neonatal cholestasis, a serious metabolic condition caused
by reduced bile secretion and fat absorption from the
gut [41].
And despite the availability of yolk lipids and oxygen,
mitochondrial oxidative metabolism in Rf- embryos
shuts down. The impairment of fatty acid β-oxidation
results in the accumulation of fatty acyl Coenzyme A
(CoA) intermediates which in turn depletes the pool of
free CoA needed to generate acetyl CoA, the point of
entry into the citric acid cycle and production of ATP
via the electron transport system and oxidative phosphorylation. Furthermore, other oxidative pathways activated by flavin-dependent enzymes and CoA would be
similarly crippled (i.e., certain aliphatic amino acids and
ketogenic pathways). In fact, both enzymes that drive ketogenesis (HMGCL and HMGCS1) were among the
highest expressed genes found in liver of Rf- embryos at
e13 and e15 (see Table 3; Figs. 3a and 9). The enzyme,
3-hydroxymethyl-3-methylglutaryl-CoA lyase (HMGCL),
catalyzes cleavage of HMG-CoA into acetyl-CoA and
acetoacetate; a key step in ketogenesis, which provides
the energy required by non-hepatic tissues, particularly
during fasting or starvation [42]. In the present case, enhanced expression of ketogenic genes in liver of
riboflavin-deficient chick embryos could be an attempt
to implement this pathway; which is blocked by their inability to oxidize yolk lipids amassed in liver. With diminution of mitochondrial ATP, non-oxidative glycolytic
metabolism generates ATP until glycogen reserves are
depleted. A last resort response to prevent metabolic
failure and hypoglycemia in Rf- embryos seems to be increased protein catabolism, as indicated by an activated
proteome and enhanced catabolism of amino acids in
liver of Rf- embryos (Tables 2 and 3; Figs. 8a and 12).
Impaired lipid metabolism was evident in the distribution of the 66 AR-DE genes involved in Fatty Acid Metabolism; 45 genes were expressed higher in the Rf +
embryos, whereas only 21 AR-DE genes were more
abundant in the Rf- embryos (see Additional file 5). The
number of AR-DE genes in several other metabolic processes (Oxidation of Lipid, Carbohydrate Metabolism,
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Cleavage of Carbohydrates, and Catabolism of Protein)
were also 2-fold greater in the Rf + embryos than Rfembryos. Nineteen AR-DE genes in the e15 embryos
were identified as flavoproteins and of these, 15 AR-DE
genes were expressed higher in Rf + liver than Rf- embryos. The large number of up-regulated genes in Rf +
embryos encoding flavoproteins demonstrates a positive
response to riboflavin rescue since their gene expression
ratio was greater, which we consider as normal.
The dependence of chicken embryos upon riboflavin
seems to be more extensive in late development (e13
and e15), when lipid catabolism becomes critical for
rapid growth and development of the embryo. Impaired
lipid metabolism (despite lipid-engorged livers), massive
hemorrhaging, delayed feathering, apoptosis and sudden
death [14] found in riboflavin-deficient embryos clearly
demonstrates the importance of this single nutrient—riboflavin—across multiple biological processes during
mid-embryonic development and the chick embryo’s absolute dependence upon yolk-lipid as the final fuel required for growth and hatching. This critical step is
unavailable to rd/rd embryos due to a mutation in the
hen’s gene encoding riboflavin-binding protein (RBP)
which prevents riboflavin transport into the fertilized
egg. This metabolic catastrophe can be avoided by a single injection of a trace amount of riboflavin into the rd/
rd fertilized egg prior to onset of incubation. The consistent pattern across multiple pathways suggests a common riboflavin-dependent mechanism; although, neither
the exact mode of action nor the biological pathways
that depend upon riboflavin still remain obscure.
Riboflavin deficiency and impaired blood clotting

We found uniform depression in expression of multiple
coagulation factors (i.e., proteases, protease inhibitors and
vitamin-dependent cofactors) in liver of Rf- embryos. Furthermore, riboflavin-deficient embryos present visually
with massive hemorrhage in skin and visceral organs (see
Fig. 1a). This malady in blood coagulation of Rf- embryos
seems related to general inhibition of both pro-coagulation factors [F2, F9, F11, FGA, FGB, and FGG; thrombinactivated fibrinolysis inhibitors (carboxypeptidase B2
(CPB2)] and anti-coagulation factors [antithrombin3
(AT3) or SERPINC1), plasminogen (PLG), vitamin Kdependent inhibitors (PROC, PROS1, and PROZ), and
alpha-2-antiplasmin (SERPINCF2)]; all of which were
expressed at higher levels in liver of Rf + embryos. A notable exception was the over-expression of plasminogen activator inhibitor 1 (PAI-1) in liver of Rf-deficient embryos
at e13 and e15 (see Table 4), which would lead to inhibition of fibrinolysis. High levels of endogenous PAI-1 are
known to cause thrombophilia in humans due to marked
inhibition of fibrinolysis [43], while over-expression of
PAI-1 in liver of the Rf- embryo could represent an
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attempt to promote blood clotting in riboflavin-deficient
embryos already experiencing marked hemophilia. It is
tempting to speculate that the broad effect of riboflavin
deficiency across both pro-coagulation and anticoagulation pathways could be due to a general lack of
phospholipids, since phospholipids are required cofactors
for activation of the blood coagulation cascade [44]. This
idea is supported by our observation of impaired lipid metabolism and phosphorylation in liver of the riboflavindeficient embryos.
While riboflavin appears to promote expression of
genes involved in acute phase response signaling and the
coagulation cascade in the liver of rd/rd chick embryos,
exposure of chick embryos to long-chain perfluoroalkyl
compounds depresses transcription of numerous acutephase response and coagulation genes in liver of e19 embryos [45], which demonstrates that these pathways are
functional and responsive in mid-to-late chick embryos.
The energy for this period of embryonic development
exclusively depends upon the ability to utilize the lipid
stored in liver and β-oxidation of lipid depends upon
flavin-dependent enzymes. Our present transcriptional
analysis of liver in rd/rd chick embryos has identified 15
flavin-dependent enzymes that respond positively to
riboflavin rescue (see Additional file 5). The human flavoproteome is composed of 90 flavin-dependent enzymes, which catalyze oxidation-reduction reactions in
major metabolic pathways (i.e., the citric acid cycle, βoxidation and degradation of amino acids) [46]. Our
current analysis of the flavoproteome in the chicken
genome (build Galgal5) indicates a similar number of
flavin-dependent homologs in the chicken. The present
microarray analysis clearly demonstrates an extensive
dependence of the hemostasis system in late cleidoic
embryos upon an essential nutrient—riboflavin. The
massive cutaneous and visceral hemorrhaging observed
in rd/rd chicken embryos (see Fig. 1a) appears to be a
direct consequence of riboflavin deficiency. The
riboflavin-deficient embryos are obviously lacking the
normal ability to control excessive cutaneous and visceral bleeding. This observation argues that riboflavin is
required for normal acquisition of a functional coagulation system in chick embryos, just as Vitamin K is required for hepatic synthesis of several coagulation
precursors secreted into the bloodstream.
Riboflavin deficiency and impaired cutaneous feathering

The possibility of riboflavin deficiency causing abnormal
feathering of chicken embryos was addressed by several
earlier studies [47, 48], although these approaches and
mixing of genetic lines limit direct comparison with our
transcriptional study on riboflavin-deficient (rd/rd) embryos derived from Single-comb White Leghorn (SCWL)
hens carrying the rd/rd gene. Therefore, our discovery
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of depressed expression of the feather keratin (F-KER)
gene in liver of riboflavin-deficient embryos is of special
interest, especially since the Rf- embryos at e15 exhibit
impaired feathering with only sparse clubbed down (see
Fig. 1a). This physical evidence of abnormal feathering
in Rf- embryos is supported by our observation of three
differentially-expressed
oligo
spots
(RIGG10897,
RIGG14163 and RIGG14953) annotated as FKER, which
showed a 19-fold increase in abundance in the liver of
Rf + embryo between e13 and e15. An even greater logfold difference in hepatic FKER expression between Rf +
and Rf- embryos was verified by qRT-PCR analysis (see
Fig. 10). Furthermore, we originally identified FKER as a
DE gene in liver of Rf + and Rf- embryos in an identical
preliminary study using our 14 K Del-Mar Chicken Integrated Systems microarray [49], where the differentially
expressed cDNA clone (pgf1n.pk001.j5 or BI064513) was
sequenced from a normalized abdominal fat cDNA library [50]. This expressed sequence tag (pgf1n.pk001.j5)
for FKER (or FK1) was mapped to chicken chromosome
1 (GGA1), which represents one of several loci for FKER
(GGA2, GGA5, GGA25 and GGA27) in the chicken genome [51]. Furthermore, phylogenetic duplication and expansion of feather diversity have expanded this multigene family to 111 complete β-keratin gene sequences
across six chromosomes (GGA1, GGA2, GGA5, GGA6,
GGA25, and GGA27) in the chicken [51]. To our knowledge, the present transcriptional study represents the
first report of FKER (FK1) expression in the liver of
chicken embryos. However, the relationship between
hepatic expression of FKER and normal expression of
FKER and other β-keratins in skin of the chicken remains unknown. Our EST clone (BI064513) derived
from a normalized abdominal fat cDNA library and the
present hepatic expression of FKER indicate that the
FKER gene is also expressed in tissues other than skin of
the chicken. A tangible explanation of the highlyexpressed FKER transcripts found presently in liver of
riboflavin-rescued chick embryos at e15 is provided by a
recent transcriptional study of the “lactating” crop sac in
broody pigeons [52]. Apparently, beta keratins, including
feather keratins, play an important structural role in the
pigeon’s crop and its production of lipid-laden crop
milk, which is fed to altricial squabs at frequent intervals. Thus, the increase in expression of FKER in liver of
e15 chick embryos could be an adaptive response that
deals with the abrupt influx of yolk lipids needed for the
embryo-to-hatchling transition. However, elucidation of
the relationship between depressed expression of FKER
in liver of Rf- embryos and cutaneous feathering, or
other impaired biological processes (i.e., blood coagulation) will require further exploration.
The timing of feather formation [53–56] coincides
with the metabolic crisis of excessive lipid accumulation
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in liver of riboflavin-deficient embryos and their inability
to utilize the stored lipid in liver. It is possible that keratin synthesis was impaired by the lack of ATP or amino
acids (i.e., l-glycine, l-proline and l-serine) available for
protein synthesis at a time when amino acids generated
from protein catabolism are forced into oxidative pathways for energy production. Feather-keratin is involved
in the elongation of barbule cells in feathers where small
proteins (i.e., β-keratins) rich in glycine, serine, and proline have evolved in birds to reinforce the mechanical resistance of feathers [57]. Interestingly, retinoic acid
signaling appears to be important for the timing and expression of FKR and other β-keratins in the avian epidermis [58]. In the present study, we found differential
expression of several enzymes involved in retinol metabolism (see Additional file 5), retinol transport and overrepresentation of RXR signaling in liver of rd/rd chick
embryos at e15 (see Table 3).
One of the most highly-expressed genes found in the
liver of riboflavin-deficient embryos was phosphoserine
phosphatase (PSPH), whose abundance was more than
20-times greater in liver of the Rf- embryos at e13 and
e15 (see Fig. 12). This enzyme is associated with the last
step in serine biosynthesis and the release of phosphate
from phosvitin, a vitellogenin protein fragment composed of more than 100 phosphoserine residues, which
represents about 80% of the total phosphorus in the
hen’s egg yolk [59]. Thus, phosvitin is an important
source of phosphate for normal development of the
avian embryo [36]. This large increase in PSPH found in
liver of riboflavin-deficient embryos could reflect the
riboflavin-deficient embryos’ increased biosynthesis of lserine. However, cutaneous feathering, beak formation
and scale/claw development on appendages are greatly
impaired in the riboflavin-deficient embryos, despite the
possible abundance of l-serine—a major component of
β-keratin in feathers [57].
Riboflavin deficiency enhances protein catabolism,
translation initiation and programed cell death

The Rf- embryos showed higher expression of 18 hepatic
genes involved in protein ubiquitination, mainly those encoding proteasome subunits (see Additional file 5) and
several members of the DnaJ heat shock protein family,
which stimulate ATPase activity. Eukaryotic Initiation Factor 2 (E1F2) signaling was also enriched in the liver of
riboflavin-deficient embryos as indicated by higher expression of 26 genes encoding a mixture of EIF subunits and
ribosomal proteins (see Additional file 4). Up-regulated
apoptosis genes found in the liver of Rf- embryos at e15
include BIRC2, CASP3, DIABLO, JUN and MAP2K2. The
initiator caspase CASP3 was more abundant in liver of Rfembryos at e13 and e15 which indicates activation of programmed cell death (apoptosis). Three dynamic processes
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are involved in apoptosis: the cleavage of effector caspases
by initiator caspases, the cytosolic translocation of proapoptotic mitochondrial proteins, and the feedback from
effector to initiator caspases [60]. The up-regulation of
several apoptosis genes in liver of riboflavin-deficient embryos likely contributes to their sudden death between e13
and e15.
From our transcriptional analyses of riboflavin deficiency in chick embryos, we discovered over-expression
of porimin (PORIMIN), a novel gene encoding an
oncosis-inducing receptor [61]. Oncotic cell death results from cell swelling and increased permeability of the
cell membrane, which could have dire consequences for
hepatocytes and endothelial cells lining blood capillaries
alike. PORIMIN-induced disruption of blood capillaries
in the riboflavin-deficient chick embryos could lead to
the massive hemorrhage of skin and visceral organs observed at e15. Our qRT-PCR analysis of PORIMIN
clearly shows over-expression of this novel gene in the
liver of riboflavin-deficient embryos at e11, e13 and e15.
There is a general consensus that oncosis is caused by
failure of ion pumps due to lack of cellular ATP, which
could be the case in riboflavin-deficient embryos that
abruptly die from hypoglycemia [16].

Conclusions
Our analysis of the liver in rd/rd embryos, with or without riboflavin rescue, across four embryonic ages (e9e15) provides the first global view of the transcriptional
responses to riboflavin deficiency and illustrates the importance of riboflavin availability for vital biological processes (i.e., β-oxidation of lipid, euglycemia, hemostasis
and feathering). Riboflavin deficiency causes sudden
death of chick embryos between e13 and e15 of development. However, injection of riboflavin before onset of
the incubation of fertile eggs rescues rd/rd embryos. The
most obvious effects of riboflavin deficiency observed in
the Rf- embryos were their smaller size, excessive lipid
accumulation in liver, massive cutaneous and visceral
hemorrhage, impaired feathering and sudden death.
Transcriptional profiling of the liver with genome-wide
oligo microarrays has revealed hundreds of genes that
are differentially expressed between Rf + and Rf- embryos at e13 and e15. Major biological pathways affected
by riboflavin deficiency include fatty acid metabolism,
blood coagulation, ubiquination/proteasome activation,
and programed cell death. These pathways are populated
by genes that are either up-regulated in the Rf + embryo
or up-regulated in the Rf- embryo. One important observation that still warrants exploration is the correlation
between reduced expression of FKER in liver of the Rfembryo and their impaired cutaneous feathering. Although Rf- embryos are able to transport and store lipids
from the yolk sac, they are unable to utilize hepatic
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lipids due to inhibition of riboflavin-dependent enzymes
required for β-oxidation of fatty acid stores. It is obvious
from the variety of biological processes affected by the
lack of riboflavin that death of Rf- embryos between e13
and e15 is due to energy depletion and the complete
shutdown of the various critical biological pathways. The
generalized disruption of blood coagulation in
riboflavin-deficient embryos and the demonstrated restoration of hemostasis gene expression by riboflavin replacement suggest that many genes in the blood clotting
cascade are either directly or indirectly dependent upon
riboflavin. However, the mechanisms by which the flavoproteome exerts these broad effects on metabolism,
hemostasis and normal embryonic development of the
chicken remain to be elucidated.
Nonetheless, our time-course transcriptional analyses
of liver in riboflavin-deficient and riboflavin-rescued (rd/
rd) embryos derived from the same genotype (rd/rd) of
SCWL (egg-type) chickens clearly demonstrates the central importance of a single required nutrient (riboflavin
or Vitamin B2) for normal growth and development of
the chicken embryo. Essentially during the last half of
rapid embryonic growth—a critical period exclusively
fueled by oxidation of yolk lipids transported into liver.
The metabolic collapse and sudden death of the
riboflavin-deficient rd/rd embryos impacts a range of
vital biological processes directly or indirectly responsive
to the riboflavin-deficient embryo’s inability to oxidize
yolk lipids, amassed in the liver. The present transcriptional study provides an excellent example of the maternal effect, where the mother’s genotype (rd/rd)
determines the survival of embryos, while the embryo’s
genotype (rd/rd) has little effect on growth and development after hatching. Thus, there is an absolute requirement for a functional riboflavin binding protein (RBP) in
the hen for transport of essential riboflavin into the fertilized egg prior to oviposition, incubation and
embryonation.

Additional files
Additional file 1: Experimental design of microarray hybridizations. A
Microsoft Excel file containing a single work sheet “Array Hybridization
Design” which describes the hybridization scheme for 32 Arizona 20.7 K
chicken oligo arrays used for the riboflavin deficient chick embryo study.
(XLSX 15 kb)
Additional file 2: Primers used for qRT-PCR analysis. A Microsoft Excel
file containing a single work sheet “qRT-PCR Primer Information”. This
table provides the chicken gene symbol, Roslin Institute Gallus gallus
(RIGG) oligo ID number, 5′-3′ sequence for forward and reverse primers,
and amplicon size (bp) for each gene used for qRT-PCR analysis. (XLSX
16 kb)
Additional file 3: Differentially-expressed (Adjusted P ≤ 0.05; FDR ≤ 0.05)
genes identified in liver of e13 and e15 embryos. A Microsoft Excel file
containing two worksheets. Work sheets “Riboflavin e13_396 DE genes”
and “Riboflavin e15_1467 DE genes” list information about differentially

Page 28 of 30

expressed genes determined by microarray analysis. Each list provides
the Roslin Institute Gallus gallus (RIGG) oligo ID, gene symbol, gene
description, log2 fold change (Rf+/Rf-), average expression (Ave/Expr), tstatistic, P-value, P-value adjusted for multiple testing (adj.P ≤ 0.05), Bstatistic from Limma software, and the Ref-Seq peptide ID for each gene
(oligo). (XLSX 328 kb)
Additional file 4: Lists of “Analysis Ready” DE genes (AR-DE genes)
assigned by IPA to “Canonical Pathways”. A Microsoft Excel file containing a
five worksheets of the top “Canonical Pathways” identified by IPA in
riboflavin-rescued and riboflavin deficient chick embryos on embryonic day
15 (e15). Five major canonical pathways identified by IPA among DE genes
on embryonic day 15 (e15) were: “EIF2 Signaling, Acute-phase Signaling,
LXR-RXR Activation, FXR-RXR Activation, Intrinsic Prothrombin Activation”,
and “Blood Clotting” in the “Biological Function Category” of IPA. Each
worksheet provides the gene symbol, Entrez gene name, gene expression
as log2 ratio (Rf+/Rf-), and Ref-Seq protein ID or Entrez gene ID. (XLSX
27 kb)
Additional file 5: IPA “Molecular and Cellular Functions” of AR-DE genes in
riboflavin-rescued and riboflavin deficient chick embryos on embryonic day
15 (e15). A Microsoft Excel file containing nine worksheets of over-populated
“Molecular and Cellular Functions” identified by IPA: “Fatty Acid Metabolism,
Oxidation of Lipid, Carbohydrate (CHO) Metabolism, Catabolism of Protein,
Metabolism of Amino Acids (AA), Protein Ubiquitination, Metabolism of
Vitamins” and 29 AR-DE genes found in the chicken “Flavoproteome”. Each
worksheet provides protein ID, gene symbol and gene expression as log2
ratio (Rf+/Rf-). (XLSX 35 kb)
Additional file 6: Pearson’s correlation analysis of gene expression
levels of 21 DE “candidate” genes determined by 20.7 K microarray
analysis and by qRT-PCR analysis. A Microsoft Excel file containing
normalized expression levels (log2 ratio of Rf+/Rf-) of 21 DE candidate
genes averaged across e13 and e15 as determined by both microarray
analysis and qRT-PCR analysis. The Pearson’s correlation coefficient
(r = 0.834; 19 degrees of freedom) indicates a highly significant (P ≤ 0.01)
correlation between gene expression levels obtained from both
microarray and qRT-PCR analyses. (XLSX 13 kb)
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